Elevance Health, Inc.

Elevance Health's RSI of 76.4 signals extreme overbought territory, yet the stock trades at a reasonable 15.4x earnings—a disconnect that suggests either the market has suddenly grown confident in near-term catalysts or momentum is outpacing fundamental valuation. The $68.4B healthcare giant sits below its 52-week high with minimal short interest (2.28%), indicating limited squeeze pressure but also minimal contrarian conviction. This combination of frothy technicals against moderate valuations creates an unstable equilibrium; a pullback would test whether the P/E multiple can hold or if overbought conditions unwind sharply. The setup feels precarious for momentum chasing but worth monitoring for value entries if RSI normalizes.